Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX) had Pre-Tax Income of $-5.37M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-5.37M |
|
-- |
|
-- |
|
$5.47M |
|
$-5.47M |
|
$0.10M |
|
|
Pre-Tax Income |
$-5.37M |
$-5.37M |
|
$-5.37M |
|
$-5.37M |
|
$-5.37M |
|
$-5.37M |
|
$-5.47M |
|
$-5.45M |
|
2.83M |
|
2.83M |
|
$-1.90 |
|
$-1.90 |
|
| Balance Sheet Financials | |
$11.64M |
|
-- |
|
$0.33M |
|
$11.97M |
|
$6.61M |
|
-- |
|
$1.42M |
|
$8.04M |
|
$3.93M |
|
$3.60M |
|
$3.93M |
|
2.01M |
|
| Cash Flow Statement Financials | |
$-8.01M |
|
$8.14M |
|
$-0.10M |
|
$3.82M |
|
$3.85M |
|
$0.03M |
|
$0.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-136.57% |
|
-149.22% |
|
-44.87% |
|
-136.57% |
|
$1.96 |
|
$-2.83 |
|
$-2.83 |
|